Live
- Oxford Grammar High School Celebrates 44th Annual Sports Day with Grandeur
- Indian banking sector’s health remains robust, govt policy working very well: Top bankers
- iOS 18.2 Unveiled: New Features with ChatGPT Integration Revolutionize Your iPhone
- 'Run for Viksit Rajasthan' to be annual event, says CM Sharma
- Nitish Kumar launches '109 free medicine vehicles' in Patna
- India have to play their best cricket at the Gabba to win series: Harbhajan
- Income tax refunds jump 46.3 pc to Rs 3.04 lakh crore in April-Nov
- Financial Intelligence Unit detects undisclosed income worth Rs 11,000 crore in 2024: Centre
- Odisha BJP chief to be elected in January
- AP Home Minister Anitha alerts officials amid rains in heavy Rains in Tirupati
Omicron BA2 subvariant spreading as EU nations lift Covid curbs: EMA
European Medicines Agency
Cases of Omicron BA2, a Covid-19 subvariant, are rising across the European Union (EU) as member nations were lifting restrictions, the European Medicines Agency (EMA) said.
Brussels: Cases of Omicron BA2, a Covid-19 subvariant, are rising across the European Union (EU) as member nations were lifting restrictions, the European Medicines Agency (EMA) said.
"While many EU countries are lifting restrictions, we notice that the infection rates are increasing again in some member states, partly because of the circulation of Omicron BA2, which seems to be more transmissible than other variants," Xinhua news agency quoted Marco Cavalieri, head of the EMA's strategy on biological health threats and vaccines, as saying to journalists here on Thursday.
What matters the most, he said, is how this increase in cases will stress the healthcare systems.
The EMA called non-vaccinated citizens to get jabbed as soon as possible, emphasizing that there are now five Covid-19 jabs authorised in the EU using different technologies.
"There is currently no evidence that immune response after vaccination is significantly different with Omicron BA2. Vaccines continue to offer high protection against hospitalization and death," he said.
The vaccines that have received conditional marketing authorisation from the EMA are those produced by Pfizer/BioNtech, Moderna, AstraZeneca, Janssen and Novavax.
